Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
52.7M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
4.39M
-
Shares change
-
+2.23M
-
Total reported value, excl. options
-
$11.1M
-
Value change
-
+$5.76M
-
Put/Call ratio
-
0.12
-
Number of buys
-
28
-
Number of sells
-
-15
-
Price
-
$2.52
Significant Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q2 2025
60 filings reported holding MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share as of Q2 2025.
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.39M shares
of 52.7M outstanding shares and own 8.33% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.05M shares), CIBC Private Wealth Group LLC (612K shares), GEODE CAPITAL MANAGEMENT, LLC (395K shares), BlackRock, Inc. (321K shares), DNB Asset Management AS (193K shares), MORGAN STANLEY (158K shares), STATE STREET CORP (139K shares), NORTHERN TRUST CORP (71.1K shares), TWO SIGMA INVESTMENTS, LP (68.9K shares), and LPL Financial LLC (44.4K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.